COPD News

An increase in exacerbations and worse lung function was found in those with advanced COPD and blood eosinophil counts less than or equal to 100 compared with those with higher counts, according to study results published in CHEST.

WASHINGTON — At 52 weeks, adults with moderate/severe COPD and type 2 inflammation receiving dupilumab had a lower exacerbation rate and better lung function, according to an American Thoracic Society International Conference presentation.

For patients with COPD hospitalized with acute exacerbations, pulmonary rehabilitation yielded better exercise capacity and quality of life vs. usual care, according to study results published in Annals of the American Thoracic Society.

WASHINGTON — Patients who experienced a COPD exacerbation had a greater risk for acute cardiovascular events than patients who did not, according to a presentation at the American Thoracic Society International Conference.

WASHINGTON — Patients with COPD on budesonide/glycopyrrolate/formoterol fumarate within 30 days of an exacerbation had fewer future exacerbations, according to data presented at the American Thoracic Society International Conference.

WASHINGTON — Initial measures of lung function were reduced in patients with COPD who lived in socially vulnerable communities, according to an abstract presented at the American Thoracic Society International Conference.

With sensors and digital resources from Propeller Health, clinicians at UC Davis Health can closely monitor daily activities of patients with COPD and asthma for early intervention, according to a press release from UC Davis Health.

WASHINGTON — Compared with dual therapies, a triple fixed-dose combination budesonide/glycopyrrolate/formoterol fumarate metered-dose inhaler showed more reductions in exacerbation rates across different COPD severity levels.

People residing in the East Coast are currently experiencing poor air quality due to smoke and haze from hundreds of wildfires in Canada.

WASHINGTON — Patients with COPD who also have depression and/or anxiety may not be receiving the treatment they need due to their respiratory disease, according to a presentation at the American Thoracic Society International Conference.